BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 11956100)

  • 1. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
    Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine.
    Liang G; Gonzales FA; Jones PA; Orntoft TF; Thykjaer T
    Cancer Res; 2002 Feb; 62(4):961-6. PubMed ID: 11861364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.
    Gonzalgo ML; Hayashida T; Bender CM; Pao MM; Tsai YC; Gonzales FA; Nguyen HD; Nguyen TT; Jones PA
    Cancer Res; 1998 Mar; 58(6):1245-52. PubMed ID: 9515812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of cell division and gene transcription in the methylation of CpG islands.
    Bender CM; Gonzalgo ML; Gonzales FA; Nguyen CT; Robertson KD; Jones PA
    Mol Cell Biol; 1999 Oct; 19(10):6690-8. PubMed ID: 10490608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
    Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
    Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cadmium exposure leads to the enhancement of lymphocyte proliferation via down-regulating p16 by DNA hypermethylation.
    Yuan D; Ye S; Pan Y; Bao Y; Chen H; Shao C
    Mutat Res; 2013 Oct; 757(2):125-31. PubMed ID: 23948183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.
    Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2005 May; 173(5):1767-71. PubMed ID: 15821584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment.
    Egger G; Aparicio AM; Escobar SG; Jones PA
    Cancer Res; 2007 Jan; 67(1):346-53. PubMed ID: 17210717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
    Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA
    Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation.
    Weisenberger DJ; Velicescu M; Cheng JC; Gonzales FA; Liang G; Jones PA
    Mol Cancer Res; 2004 Jan; 2(1):62-72. PubMed ID: 14757847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene induction and apoptosis in human hepatocellular carci-noma cells SMMC-7721 exposed to 5-aza-2'-deoxycytidine.
    Fan H; Zhao ZJ; Cheng YC; Shan YF; Lu ZH; Zhang JQ; Xie W
    Chin Med J (Engl); 2007 Sep; 120(18):1626-31. PubMed ID: 17908484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.
    Costello JF; Berger MS; Huang HS; Cavenee WK
    Cancer Res; 1996 May; 56(10):2405-10. PubMed ID: 8625319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
    Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
    Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.